Mode
Text Size
Log in / Sign up

Dental antibiotic prophylaxis does not reduce periprosthetic joint infection risk in total joint arthroplasty patientsRoutine dental antibiotics do not lower infection risk for joint replacement patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider limiting dental antibiotic prophylaxis to select high-risk TJA patients.

This systematic review and meta-analysis examined the association between dental antibiotic prophylaxis and the risk of periprosthetic joint infection in adult patients who had total joint arthroplasty. The study population consisted of 157466 individuals. The setting details were not reported in the source data. The intervention involved dental antibiotic prophylaxis, while the comparator group consisted of nonantibiotic groups. The primary outcome measured was periprosthetic joint infection risk. Secondary outcomes were not reported. The follow-up duration was not reported.

The main results indicated no significant difference in periprosthetic joint infection risk between the two groups. The incidence of periprosthetic joint infection ranged from 0.07 to 0.3%. The effect size was not reported. The direction of the effect showed a slight, nonsignificant increase in risk among patients receiving antibiotics. The p-value or confidence interval was not reported.

Safety and tolerability findings were not reported. Adverse events were not reported. Serious adverse events were not reported. Discontinuations were not reported. Tolerability was not reported. This lack of safety data limits the ability to fully weigh the risks and benefits of routine prophylaxis.

These results contrast with prior landmark studies in this therapeutic area which often supported broader prophylaxis use. The current evidence suggests that routine use of prophylaxis before dental procedures in patients who have primary total hip or knee arthroplasty does not reduce the risk of periprosthetic joint infection. Current evidence supports limiting prophylaxis to select high-risk populations.

Key methodological limitations and potential biases were not reported in the source data. Funding or conflicts of interest were not reported. The absence of reported limitations suggests that the review may have relied on existing data without detailed critique of study quality or bias.

The clinical implications are clear for practice decisions. Routine antibiotic prophylaxis is not recommended for all patients with total joint arthroplasty undergoing dental procedures. Instead, clinicians should consider limiting prophylaxis to select high-risk populations. This approach aligns with current evidence and may reduce unnecessary antibiotic exposure.

Several questions remain unanswered. The specific characteristics of high-risk populations that warrant prophylaxis were not detailed. The long-term impact of antibiotic stewardship on periprosthetic joint infection rates was not reported. The optimal timing and type of prophylaxis for high-risk patients remain undefined. Further research is needed to clarify these aspects of clinical management.

People with hip or knee replacements often worry about dental work. They fear that brushing their teeth or getting a filling could let bacteria enter their bloodstream and infect their artificial joint. Because of this fear, many doctors prescribe antibiotics before any dental procedure. But does this routine practice actually help? A new large review says no. It found that taking these drugs before dental visits does not lower the risk of infection for patients with total joint replacements.

The researchers looked at a huge group of people. They analyzed data for 157,466 adults who had total joint arthroplasty. This is the surgery to replace a hip or knee with an artificial joint. These patients were scheduled for dental procedures. Some took antibiotics before the visit. Others did not take any antibiotics. The study compared how often infections happened in these two groups.

The main result was clear. There was no significant difference in infection risk between the two groups. The infection rate was very low in everyone. It ranged from 0.07 percent to 0.3 percent. This means fewer than one in every hundred people got an infection. The study noted a slight, nonsignificant increase in risk for those who took antibiotics. This suggests the drugs might not be doing any good and could even be slightly risky in rare cases.

Safety was also checked. The review did not report specific adverse events or serious side effects. However, the lack of benefit means patients are exposed to unnecessary medication. Antibiotics can cause stomach issues or other problems. Taking them when they are not needed adds risk without reward. The study did not report discontinuations or tolerability issues, but avoiding unnecessary drugs is always safer.

People should not overreact to this single study. It is a meta-analysis, which combines many smaller studies. This makes the findings very strong. The evidence supports limiting prophylaxis to select high-risk populations. This means doctors should only give antibiotics to a few specific patients who are truly at high risk. For most people with a new joint, routine use of prophylaxis before dental procedures does not reduce the risk of PJI.

What this means for patients right now is simple. You do not need to take antibiotics before a dental visit just because you have a joint replacement. Talk to your dentist and doctor. They can decide if you are in that select high-risk group. For the vast majority, skipping the antibiotic is the right choice. It keeps you safe and avoids unnecessary medicine while protecting your joint from infection.

What this means for you:
Routine dental antibiotics do not lower infection risk for most joint replacement patients.

Study Details

Study typeMeta analysis
Sample sizen = 157,466
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BACKGROUND: Periprosthetic joint infection (PJI) is a serious complication following total joint arthroplasty (TJA). Hematogenous spread, including from dental procedures, is a proposed mechanism for PJI. While prophylactic antibiotics (PAs) have traditionally been recommended before dental procedures in patients with joint prostheses, recent guidelines question their effectiveness. This study aimed to evaluate the association between dental antibiotic prophylaxis and PJI risk through a systematic review and meta-analysis. METHODS: A systematic literature search was conducted using PubMed, Embase, and Cochrane databases in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies included adult patients who had TJAs undergoing dental procedures, with and without antibiotic prophylaxis, and reported PJI outcomes. There were four retrospective cohort studies, encompassing 157,466 patients, that met the inclusion criteria. Study quality was assessed using the Newcastle-Ottawa Scale. A random-effects meta-analysis with Hartung-Knapp adjustment was used to pool odds ratios. RESULTS: Incidence of PJI ranged from 0.07 to 0.3% across included studies. There were no studies that demonstrated a statistically significant reduction in PJI rates among patients who received PAs. Meta-analysis showed no significant difference in PJI risk between antibiotic and nonantibiotic groups, with a slight, nonsignificant increase in risk among patients receiving antibiotics. Several studies identified other PJI risk factors, including revision arthroplasty, obesity, congestive heart failure, and diabetes with end-organ damage. CONCLUSIONS: Routine use of PAs before dental procedures in patients who have primary total hip or knee arthroplasty does not reduce the risk of PJI. Given the low overall incidence of PJI and the potential harms of unnecessary antibiotic use, including resistance and adverse effects, current evidence supports limiting prophylaxis to select high-risk populations. Updated clinical guidelines should reflect these findings to enhance antibiotic stewardship and reduce health care costs.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.